2023 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-21
±³À°ÀÏÀÚ : 2023-04-21
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ : 2023 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258
À̸ÞÀÏ : herz8@circulation.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ-100,000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-70,000ÇöÀåµî·Ï: ±³¼ö ¹× °³¿øÀÇ-120,000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-90,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-21 Rm.207 09:30~09:50 Cardiovascular Regeneration Àå¿ìö(ºÎ»ê´ëÇб³)
±³À°½Ã°£ 04-21 Rm.207 09:50~10:10 Development of cell therapeutics for myocardial infarction based on iPSC-derived spheroids ¹ÚÈÆÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-21 Rm.207 10:10~10:30 Gene-environment Interactions in Cardiovascular Disease ±èÀç¹Î(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04-21 Rm.207 10:30~10:50 Neuroscience Therapeutics for Cardiometabolic Diseases ÃÖÇüÁø(¼¿ïÀÇ´ë)
Åä·Ð 04-21 Rm.207 10:50~11:00 Discussion ()
ÈÞ½Ä 04-21 11:00~11:10 Break ()
±³À°½Ã°£ 04-21 Convention Hall 2 11:10~11:25 How to Deal with Patients with Anxiety and Chest pain as a Cardiologist À̺À±â(°¿øÀÇ´ë)
±³À°½Ã°£ 04-21 Convention Hall 2 11:25~11:40 Assessment and Treatment of Depression in Cardiac Patients ±èÀç¹Î(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04-21 Convention Hall 2 11:40~11:55 My Experience with Psychiatric Medications in Patients with Arrhythmia ½ÉÀç¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-21 Convention Hall 2 11:55~12:10 How to use Psychiatric Medications Properly and Safely in Cardiology Patients ±èÁÖ¿Ï(Àü³²ÀÇ´ë)
Åä·Ð 04-21 Convention Hall 2 12:10~12:40 Discussion ()
ÈÞ½Ä 04-21 12:40~12:45 Break ()
±³À°½Ã°£ 04-21 Rm.207 12:45~13:05 Eagle's Eye View: How to Get Patients on a Statin Timely and Keep Them on It ÇÑÁ¤±Ô(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-21 Rm.207 13:05~13:25 Start Tailored approach on cholesterol management for ASCVD patients ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)
ÈÞ½Ä 04-21 13:25~13:30 Break ()
±âŸ 04-21 Rm.207 13:30~14:20 Case ¹ßÇ¥ ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 04-21 14:20~14:30 Break ()
±³À°½Ã°£ 04-21 Rm.212 14:30~14:50 Treatment of Resistant Hypertension: Overview ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-21 Rm.212 14:50~15:10 Aldosterone Antagonists in Resistant Hypertension ±èÇöÁø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-21 Rm.212 15:10~15:30 Endothelin Receptor Antagonists in Resistant Hypertension Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-21 Rm.212 15:30~15:50 Latest Updates on Renal Denervation: Is It Ready? ±èÁÖÇÑ(Àü³²ÀÇ´ë)
Åä·Ð 04-21 Rm.212 15:50~16:00 Discussion ()
ÈÞ½Ä 04-21 16:00~16:10 Break ()
±³À°½Ã°£ 04-21 Convention Hall 3 16:10~16:30 Current Status and Barriers of Cardiac Rehabilitation in Korea ±èö(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 04-21 Convention Hall 3 16:30~16:50 Using Information and Communication Technology for Cardiac Rehabilitation ÀÌÀå¿ì(±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø)
±³À°½Ã°£ 04-21 Convention Hall 3 16:50~17:10 Hybrid Cardiac Rehabilitation for Heart Failure Patients ¼ºÁöµ¿(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-21 Convention Hall 3 17:10~17:30 Community-based Cardiac Rehabilitation ÇÑÀ翵(Àü³²ÀÇ´ë)
Åä·Ð 04-21 Convention Hall 3 17:30~17:40 Discussion ()